Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FBXW7 |
Variant | R465C |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | FBXW7 R465C lies within WD repeat 3 of the Fbxw7 protein (UniProt.org). R465C confers a loss of Fbxw7 protein function as demonstrated by a loss of Fbxw7-substrate interaction and impaired substrate degradation by Fbxw7, resulting in sustained Notch1 intracellular domain and Myc expression (PMID: 17646409), impaired degradation of Klf5 (PMID: 28963353), aberrant subnuclear localization relative to wild-type Fbxw7 in culture (PMID: 30510140), and reduced suppression of migration, invasion, and colony formation in culture (PMID: 31161818). |
Associated Drug Resistance | |
Category Variants Paths |
FBXW7 mutant FBXW7 inact mut FBXW7 R465C |
Transcript | NM_033632.3 |
gDNA | chr4:g.152328233G>A |
cDNA | c.1393C>T |
Protein | p.R465C |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_024454123.2 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
NM_033632.3 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_024454122.1 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_011532084.3 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_047415901.1 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_017008362 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
NM_001349798.2 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
NM_001349798.1 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_047415898.1 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_011532085 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_047415900.1 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_047415897.1 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_024454121.1 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_024454124.1 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_047415899.1 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_011532083 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_024454123.1 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_011532085.2 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_011532084.2 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_011532085.3 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
XM_011532084 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
NM_033632.3 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
NM_033632 | chr4:g.152328233G>A | c.1393C>T | p.R465C | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
FBXW7 R465C | T-cell adult acute lymphocytic leukemia | resistant | MRK-003 | Preclinical | Actionable | In a preclinical study, FBXW7 R465C conferred resistance to gamma secretase inhibitor, MRK-003, by activation of the NOTCH pathway and stablization of MYC as demonstrated in T cell acute lymphoblastic leukemia (T-ALL) cell lines (PMID: 17646409). | 17646409 |